AVENTIS has agreed to the improved take over offer made from its competitor SANOFI-SYNTHELABO. The operation has just been approved by the European competition authorities and will give rise to the third largest pharmaceutical group in the world after the US group PFIZER and GLAXOSMITHKLINE, Britain. SANOFI finally offered EUR 55 bn for AVENTIS, the equivalent to EUR 68.93 per share (as opposed to 60.43 proposed initially), 5 SANOFI shares and EUR 120 in cash for six AVENTIS shares. The...